Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

Share Price is delayed by 15 minutes
Get Live Data
912.00    16.00 (1.79%)
Bid:
912.00
Ask:
913.00
Spread: 1.00 (0.11%)
Market Cap: £131.21b
BNC Live PriceLast checked at - London Stock Exchange

Intraday Banco Santander Share Chart

New financial reporting

4 Apr 2022 17:39

RNS Number : 2192H
Banco Santander S.A.
04 April 2022
 

Banco Santander, S.A. (the "Bank" or "Banco Santander"), in compliance with the Securities Market legislation, hereby communicates the following:

 

OTHER RELEVANT INFORMATION

 

From and including the first quarter of 2022, a change in Grupo Santander's (the "Group") financial reporting of segments will be carried out to reflect two main modifications, as described below. The attached presentation includes the Group's quarterly pro forma financial figures for 2021 reported on this new basis to allow a comparison between 2021 and 2022 results.http://www.rns-pdf.londonstockexchange.com/rns/2192H_1-2022-4-4.pdf

Aiming at providing more transparency and a better capital allocation to continue enhancing our profitability, the main modifications are as follows:

 

Reallocation of certain financial costs of the Corporate Centre segment in the Group's results to the business units:

Further clarity in the MREL/TLAC regulation[1] makes it possible to better allocate the cost of the eligible debt issuances to the business units;

In addition, other financial costs, primarily the cost of funding the excess capital held by the business unit above of Group's CET1 ratio have been reassigned accordingly.

Downsizing of Other Europe:

The Corporate and Investment Banking (CIB) branches of Banco Santander in Europe and other business lines previously reported under "Other Europe" have been now integrated into the Spain unit to reflect how the business will be managed and supervised, in line with other regions.

 

The abovementioned changes have no impact on the Group's reported consolidated financial figures nor on the Group's consolidated financial targets that have been set for the future.

 

A presentation will take place tomorrow, Tuesday 5 April 2022, at 13:00 hrs (Madrid time). For further information, please contact Investor Relations (investor@gruposantander.com).

 

 

Boadilla del Monte (Madrid), 4 April 2022

 

 

 

[1]- MREL: Minimum Requirement for Own Funds and Eligible Liabilities, binding minimum requirement for own funds and eligible liabilities, both total and subordinated, with loss absorption capacity, which is required to be met under the Bank Recovery and Resolution Directive (BRRD).

- TLAC: Total loss absorbing capacity, requirement which is required to be met under the Capital Requirements Directive V (CRD V) package.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSSFFMLEESEDL
Date   Source Headline
11th Jun 202611:02 amRNSBuyback programme: transactions 4-10June
10th Jun 20268:35 amRNSResult of Tender Offer
5th Jun 20263:06 pmRNSDirector/PDMR Shareholding
4th Jun 202611:05 amRNSBuyback programme: transactions 28May-3June
1st Jun 20264:47 pmRNSTotal Voting Rights
28th May 20267:00 amRNSAT1s Contingent Convertible securities
27th May 20268:26 amRNSOffer to purchase outstanding instruments
27th May 20268:21 amRNSResumption of the share buyback programme
13th May 20263:03 pmRNSRating granted by Fitch Ratings
6th May 20263:08 pmRNSDirector/PDMR Shareholding
1st May 20267:08 amRNSFurther re: Santander to acquire TSB
30th Apr 20264:59 pmRNSTotal Voting Rights
29th Apr 20267:00 amRNS1Q2026 Financial report & Earnings presentation
29th Apr 20267:00 amRNSFirst Quarter 2026 Results - Press release
24th Apr 202611:14 amRNSBuyback programme: transactions 16-23Apr
23rd Apr 20267:40 amRNSProspectus Exemption
23rd Apr 20267:25 amRNSTemporary suspension of the share buyback program
22nd Apr 202611:09 amRNS1st Quarter 2026 Results Notice
16th Apr 202611:04 amRNSBuyback programme: transactions 8-15Apr
14th Apr 20264:58 pmRNSSantander informs of the MREL determined by SRB
8th Apr 202611:07 amRNSBuyback programme: transactions 26Mar-7Apr
31st Mar 20264:44 pmRNSTotal Voting Rights
27th Mar 20262:26 pmRNS2026 AGM - Resolutions
27th Mar 20267:06 amRNSSantander expects higher profit&reaffirms targets
26th Mar 202610:12 amRNSBuyback programme: transactions 19-25Mar
19th Mar 20265:01 pmRNSDirector/PDMR Shareholding
19th Mar 202611:17 amRNSBuyback programme: transactions 12-18Mar
13th Mar 20264:37 pmRNSDirector/PDMR Shareholding
12th Mar 202611:10 amRNSBuyback programme: transactions 5-11Mar
9th Mar 202611:17 amRNSDirector/PDMR Shareholding
9th Mar 202611:14 amRNSDirector/PDMR Shareholding
6th Mar 20264:18 pmRNSDirector/PDMR Shareholding
5th Mar 202611:16 amRNSBuyback programme: transactions 27Feb-4Mar
4th Mar 20265:58 pmRNSDirector/PDMR Shareholding
2nd Mar 20265:57 pmRNSTotal Voting Rights
27th Feb 202611:18 amRNSBuyback programme: transactions 19-26Feb
25th Feb 20266:01 pmRNSNotice of AGM
25th Feb 20265:20 pmRNS2025 UK Annual Report
25th Feb 20262:19 pmRNSInvestor Day: Group CFO presentation
25th Feb 202612:42 pmRNSInvestor Day: Group CEO presentation
25th Feb 202612:37 pmRNSInvestor Day: Executive chair presentation
25th Feb 20267:03 amRNSStrategic plans, profit forecasts & payout policy
25th Feb 20267:00 amRNSDividend declaration & agreement to call 2026 AGM
24th Feb 20263:05 pmRNSDirector/PDMR Shareholding
23rd Feb 20264:54 pmRNSDirector/PDMR Shareholding
19th Feb 202611:29 amRNSBuyback programme: transactions 12-18Feb
18th Feb 20264:48 pmRNSDirector/PDMR Shareholding
18th Feb 202611:07 amRNSInvestor Day meeting announcement
12th Feb 20263:02 pmRNSBuyback programme: transactions 4-11Feb
10th Feb 20265:09 pmRNSChanges to the presentation of Group’s information

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.